Global investor meetings for Dr. Reddy’s (NYSE: RDY) in May–June 2026

Rhea-AI Filing Summary

Dr. Reddy’s Laboratories filed a Form 6-K to share its schedule of analyst and institutional investor meetings. The company’s management will attend a series of in-person group meetings at investor conferences organized by Elara Capital, Bank of America, Nomura and Investec.

Sessions are planned across multiple financial centers between May 20, 2026 and June 3, 2026, including Hong Kong, Singapore, Toronto, Boston, New York and Princeton, New Jersey. The company notes that this schedule may change if required by investors or the company.

Key Figures

Meeting window start: May 20, 2026 Meeting window end: June 3, 2026 Elara Capital session time: 09:00 - 18:00 HKT +3 more

6 metrics

Meeting window start May 20, 2026 First scheduled investor group meeting date

Meeting window end June 3, 2026 Last scheduled investor group meeting date

Elara Capital session time 09:00 - 18:00 HKT Hong Kong group meet on May 20, 2026

Bank of America session time 08:30 - 18:00 SGT Singapore group meets on May 21-22, 2026

Nomura New York short session 09:00 - 14:00 Group meet in New York on May 29, 2026

Investec Princeton session 10:30 - 11:30 Group meet in Princeton on June 3, 2026

Key Terms

Form 6-K, foreign private issuer, Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, analyst / institutional investor meetings, +1 more

5 terms

Form 6-K regulatory

"SECURITIES AND EXCHANGE COMMISSION Form 6-K REPORT OF FOREIGN PRIVATE ISSUER"

A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.

foreign private issuer regulatory

"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16"

A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.

Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 regulatory

"Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015"

analyst / institutional investor meetings financial

"Schedule of Analyst / Institutional Investor Meetings"

Group Meet financial

"Meeting mode | Nature of meet | Timing ... In-Person | Group Meet"

Form 6-K: How Foreign Companies Report to the SEC →

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

May, 2026

Commission File Number 1-15182

DR. REDDY’S LABORATORIES LIMITED

(Translation of registrant’s name into English)

8-2-337, Road No. 3, Banjara Hills

Hyderabad, Telangana 500 034, India

+91-40-49002900

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  x                                   Form 40-F   ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

Note:  Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ______

Note:  Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.

Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes  ¨                                   No   x

If “Yes” is marked, indicate below the file number assigned to registrant in connection with Rule 12g3-2(b): 82-________.

EXHIBITS

Exhibit Number		Description of Exhibits
99.1		Intimation dated May 16, 2026

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	DR. REDDY’S LABORATORIES LIMITED (Registrant)
Date: May 16, 2026	By:	/s/ K Randhir Singh
		Name:	K Randhir Singh
		Title:	Company Secretary

3

Exhibit 99.1

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India CIN: L85195TG1984PLC004507 Tel:       + 91 40 4900 2900 Fax:     + 91 40 4900 2999 Email: mail@drreddys.com Web:   www.drreddys.com

May 16, 2026

National Stock Exchange of India Ltd. (Scrip Code: DRREDDY)

BSE Limited (Scrip Code: 500124)

New York Stock Exchange Inc. (Stock Code: RDY)

NSE IFSC Ltd. (Stock Code: DRREDDY)

Dear Sir/Madam,

Sub: Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Schedule of Analyst / Institutional Investor Meetings

This is to inform that the Company’s management will be participating in the following investor conference with single institution(s)/ investor groups:

Date	Organized by	Location	Meeting mode	Nature of meet	Timing
20.05.2026	Elara Capital	Hong Kong	In-Person	Group Meet	09:00 - 18:00 HKT
21.05.2026 – 22.05.2026	Bank of America	Singapore	In-Person	Group Meet	08:30 - 18:00 SGT
25.05.2026	Nomura	Toronto	In-Person	Group Meet	09:00 - 18:00 ET
28.05.2026	Nomura	Boston	In-Person	Group Meet	09:00 - 18:00 ET
29.05.2026	Nomura	New York	In-Person	Group Meet	09:00 - 14:00 ET
01.06.2026 – 02.06.2026	Nomura	New York	In-Person	Group Meet	09:00 - 18:00 ET
03.06.2026	Investec	Princeton, New Jersey	In-Person	Group Meet	10:30 - 11:30 ET

Please note that the schedule of the aforesaid meeting is subject to change due to any exigencies on the part of Investors / Company.

This is for your information.

Thanking you.

Yours faithfully,

For Dr. Reddy’s Laboratories Limited

K Randhir Singh

Company Secretary, Compliance Officer & Head-CSR

FAQ

What does Dr. Reddy’s Laboratories (RDY) disclose in this Form 6-K?

Dr. Reddy’s Laboratories discloses a detailed schedule of upcoming analyst and institutional investor meetings. It lists conference organizers, locations, dates, meeting modes, and time windows for each group meeting across several global financial centers.

When are Dr. Reddy’s (RDY) analyst and investor meetings scheduled for 2026?

The company’s management plans investor meetings from May 20, 2026 to June 3, 2026. The schedule covers multiple days with Bank of America and Nomura conferences, plus single-day events with Elara Capital and Investec in Asia and North America.

Where will Dr. Reddy’s Laboratories (RDY) hold its upcoming investor meetings?

Investor meetings are scheduled in Hong Kong, Singapore, Toronto, Boston, New York and Princeton, New Jersey. All sessions are described as in-person group meets, hosted by major financial institutions including Elara Capital, Bank of America, Nomura and Investec.

Are the Dr. Reddy’s (RDY) analyst and investor meeting dates fixed?

The company notes that the meeting schedule is subject to change if required by investors or the company. While specific dates, times and locations are provided, they may be adjusted in response to exigencies affecting either party involved.

Which institutions are organizing Dr. Reddy’s (RDY) investor conferences?

Conferences are organized by Elara Capital, Bank of America, Nomura and Investec. Each is hosting in-person group meetings with Dr. Reddy’s management in different cities, giving institutional investors multiple opportunities to interact with company representatives.

Filing Exhibits & Attachments

1 document

Press Releases

• EX-99.1 EXHIBIT 99.1 56.2 KB